Monitor for Cognitive Function Impairment in Patients With NPC After IMRT
A cross-sectional study examined the correlation between cognitive function and sleep quality and negative affect in patients with nasopharyngeal carcinoma after radiotherapy.
Diagnosis & Disease Information
Telephone Intervention Improves Care Management in Radiotherapy for HNC
A quality improvement project sought to improve pain management in patients undergoing radiation therapy for head and neck cancer.
Early Death May Be Common in Cancer Patients Taking Immune Checkpoint Inhibitors
Results of a real-world study suggest that early death may be common among cancer patients taking immune checkpoint inhibitors.
New Scale Quantifies Workload, Increases Productivity of Oncology Nurse Navigators
Study results show a new productivity scale measures the workloads of oncology nurse navigators and assists in increasing their productivity.
Multidisciplinary Rounds, Standardized Order Sets Improve Care in Radiotherapy for HNC
A standardized care plans for patients with HNC undergoing radiotherapy in the inpatient and outpatient settings were presented at the ONS Congress 2023.
Will the Human Microbiome Yield Improvements to Cancer Radiotherapy?
An exploration of the human microbiome and the impact it may have on current and future cancer therapies.
Adding Ipilimumab to Nivolumab Provides No Benefit in Recurrent or Metastatic HNSCC
Adding ipilimumab to treatment with nivolumab does not improve response or survival outcomes in recurrent/metastatic HNSCC, a phase 2 trial suggests.
Could Mean Platelet Volume Serve as a Prognostic Indicator for Outcomes in Cancer?
Researchers sought to determine the predictive value of mean platelet volume as a marker for cancer outcomes.
Patient-Clinician Identity Discordance Influences Whether Cancer Survivors Seek Care
Cancer survivors may be more likely to delay or forgo care if their treating clinician is of a different race, gender, or other identity, a new study suggests.
Selective NLRP3 Inhibitor Fast Tracked for Prevention, Reduction of Severe Oral Mucositis
RRx-001 is an investigational small molecule inflammasome NLRP3 inhibitor and Nrf2 upregulator with antioxidant and anti-inflammatory properties.
- Loading...
Loading...
Next post in Head and Neck Cancer
Loading... 
Loading...